GraniteShares ETF Trust - GraniteShares YieldBOOST CRCL ETF (CRY)

NASDAQ: CRY · Real-Time Price · USD
0.00
+7.08 (39.57%)
At close: Apr 28, 2026, 4:00 PM EDT
24.96
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:15 PM EDT
Assetsn/a
Expense Ration/a
PE Ration/a
Shares Outn/a
Dividend (ttm)n/a
Dividend Yieldn/a
Ex-Dividend Daten/a
Payout Frequencyn/a
Payout Ration/a
Volume50
Open24.96
Previous Close17.88
Day's Range24.96 - 24.96
52-Week Lown/a
52-Week Highn/a
Betan/a
Holdingsn/a
Inception Daten/a

About CRY

Fund Home Page

GraniteShares ETF Trust - GraniteShares YieldBOOST CRCL ETF is an exchange-traded fund launched by GraniteShares Inc. The fund is managed by GraniteShares Advisors LLC. It invests in public equity markets. The fund invests through derivatives in stocks of companies operating across software and services sectors. It uses derivatives such as options to create its portfolio. It invests in growth and value stocks of companies across diversified market capitalizations. GraniteShares ETF Trust - GraniteShares YieldBOOST CRCL ETF is domiciled in the United States.

Stock Exchange NASDAQ
Ticker Symbol CRY
ETF Provider GraniteShares

News

CryoLife Announces Corporate Rebranding and Changes Name to Artivion

ATLANTA, Jan. 18, 2022 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it was renaming and rebranding itself ...

4 years ago - PRNewsWire

A Trio of Low Price-Sales Ratio Stocks

Value investors may find the following stocks to be attractive opportunities, as they have low price-sales ratios compared to the S&P 500 and good profitability.

Other symbols: AROCVSEC
4 years ago - GuruFocus

CryoLife to Participate in the Canaccord Genuity Virtual MedTech, Diagnostics, and Digital Health & Services Forum

ATLANTA, Nov. 9, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that members of management will host one-on-...

4 years ago - PRNewsWire

Recap: Cryolife Q3 Earnings

Cryolife (NYSE:CRY) reported its Q3 earnings results on Thursday, November 4, 2021 at 04:05 PM. Here's what investors need to know about the announcement.

4 years ago - Benzinga

CryoLife Reports Third Quarter 2021 Financial Results

ATLANTA, Nov. 4, 2021 /PRNewswire/ -- Third Quarter and Recent Business Highlights: Achieved total revenues of $72.2 million in the third quarter 2021 versus $65.1 million in the third quarter of 2020...

4 years ago - PRNewsWire

CryoLife Announces Release Date and Teleconference Call Details for Third Quarter 2021 Financial Results

ATLANTA, Oct. 20, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that third quarter 2021 financial results w...

4 years ago - PRNewsWire

Anthony Semedo Joins CryoLife Board of Directors

ATLANTA, Sept. 22, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today the appointment of Anthony "Tony" Semedo t...

4 years ago - PRNewsWire

CryoLife to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference

ATLANTA, Aug. 31, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the upcoming Mo...

5 years ago - PRNewsWire

CryoLife to Participate in Upcoming Virtual Investor Conferences

ATLANTA, Aug. 2, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in two upcoming vir...

5 years ago - PRNewsWire

Cryolife: Q2 Earnings Insights

Shares of Cryolife (NYSE:CRY) rose 2.9% in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share rose 700.00% year over year to $0.12, which beat the estimat...

5 years ago - Benzinga

CryoLife Reports Second Quarter 2021 Financial Results

ATLANTA, July 29, 2021 /PRNewswire/ -- Second Quarter and Recent Business Highlights: Achieved total revenues of $76.1 million in the second quarter 2021 versus $53.8 million in the second quarter of ...

5 years ago - PRNewsWire

CryoLife Announces Sale of PerClot to Baxter

ATLANTA, July 29, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it has completed the sale of its PerCl...

Other symbols: BAX
5 years ago - PRNewsWire

Baxter Announces Acquisition of PerClot Polysaccharide Hemostatic System to Expand Advanced Surgery Portfolio

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leading global medical products company, announced its Baxter Healthcare Corporation subsidiary has completed the acquisition ...

Other symbols: BAX
5 years ago - Business Wire

CryoLife Announces Release Date and Teleconference Call Details for Second Quarter 2021 Financial Results

ATLANTA, July 15, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that second quarter 2021 financial results ...

5 years ago - PRNewsWire

CryoLife to Participate in the UBS Global Healthcare Virtual Conference

ATLANTA, May 18, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the upcoming UBS...

5 years ago - PRNewsWire

Cryolife: Q1 Earnings Insights

Shares of Cryolife (NYSE:CRY) rose in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share increased 137.50% year over year to $0.03, which beat the estimat...

5 years ago - Benzinga

CryoLife Reports First Quarter 2021 Financial Results

ATLANTA, April 29, 2021 /PRNewswire/ -- First Quarter and Recent Business Highlights: Achieved total revenues of $71.1 million in the first quarter 2021 versus $66.4 million in the first quarter of 20...

5 years ago - PRNewsWire

CryoLife Announces Release Date and Teleconference Call Details for First Quarter 2021 Financial Results

ATLANTA, April 15, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that first quarter 2021 financial results ...

5 years ago - PRNewsWire

CryoLife to Participate in 20th Annual Needham Virtual Healthcare Conference

ATLANTA, April 7, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the upcoming 20...

5 years ago - PRNewsWire

CryoLife to Participate in Oppenheimer 31st Annual Virtual Healthcare Conference

ATLANTA, March 9, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the upcoming Op...

5 years ago - PRNewsWire

Recap: Cryolife Q4 Earnings

Shares of Cryolife (NYSE:CRY) rose in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share increased 81.82% over the past year to $0.20, which beat the esti...

5 years ago - Benzinga

CryoLife to Host Webcast Discussing PROACT Xa Clinical Trial on December 7, 2020

ATLANTA, Nov. 19, 2020 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will host a webcast for investors a...

5 years ago - PRNewsWire

CryoLife Announces Release Date and Teleconference Call Details for 2020 Third Quarter Financial Results

ATLANTA, Oct. 21, 2020 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that 2020 third quarter financial results w...

5 years ago - PRNewsWire

CryoLife to Present at the 18th Annual Morgan Stanley Global Healthcare Conference

ATLANTA, Sept. 8, 2020 /PRNewswire/ -- CryoLife, Inc.

6 years ago - PRNewsWire

CryoLife Acquires Ascyrus Medical

ATLANTA, Sept. 2, 2020 /PRNewswire/ -- CryoLife, Inc.

6 years ago - PRNewsWire

CryoLife Reports Second Quarter 2020 Financial Results

ATLANTA, July 30, 2020 /PRNewswire/ -- Second Quarter and Recent Business Highlights: Achieved total revenues of $53.8 million in the second quarter 2020 versus $71.1 million in the second quarter of ...

6 years ago - PRNewsWire

CryoLife Announces Release Date and Teleconference Call Details for 2020 Second Quarter Financial Results

ATLANTA, July 21, 2020 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that 2020 second quarter financial results ...

6 years ago - PRNewsWire

CryoLife Announces Pricing of $100 Million Convertible Senior Notes Offering

ATLANTA, June 19, 2020 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY) ("CryoLife" or "the Company"), a leading cardiac and vascular surgery company focused on aortic disease, today announced the pricing o...

6 years ago - PRNewsWire

CryoLife to offer $100 million of 5-year convertible notes

CryoLife Inc. CRY, -0.72% said Thursday it is planning to offer $100 million in convertible senior notes that mature in 2024 in a private placement, joining the many companies issuing debt to bolster ...

6 years ago - Market Watch

CryoLife Announces Offering of Convertible Senior Notes Due 2025

ATLANTA, June 18, 2020 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY) ("CryoLife" or "the Company"), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it inten...

6 years ago - PRNewsWire